Daytona Street Capital LLC Invests $2.69 Million in CVS Health Corporation $CVS

Daytona Street Capital LLC purchased a new position in shares of CVS Health Corporation (NYSE:CVS) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 33,888 shares of the pharmacy operator’s stock, valued at approximately $2,689,000. CVS Health accounts for 1.8% of Daytona Street Capital LLC’s investment portfolio, making the stock its 16th largest holding.

Other hedge funds and other institutional investors have also bought and sold shares of the company. National Pension Service lifted its holdings in CVS Health by 3.1% in the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock valued at $301,532,000 after buying an additional 119,189 shares during the period. Kingsview Wealth Management LLC lifted its holdings in CVS Health by 316.2% in the third quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock valued at $7,873,000 after buying an additional 79,340 shares during the period. AE Wealth Management LLC lifted its holdings in CVS Health by 6.2% in the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock valued at $19,391,000 after buying an additional 14,983 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its holdings in CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock valued at $16,971,000 after buying an additional 22,653 shares during the period. Finally, Alpha Omega Wealth Management LLC lifted its holdings in CVS Health by 12.3% in the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after buying an additional 16,418 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE CVS opened at $73.24 on Tuesday. The firm’s 50-day moving average price is $75.52 and its 200-day moving average price is $77.72. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The firm has a market capitalization of $93.17 billion, a P/E ratio of 53.07, a P/E/G ratio of 0.77 and a beta of 0.51. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.6%. CVS Health’s payout ratio is presently 192.75%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. TD Cowen restated a “buy” rating on shares of CVS Health in a report on Friday, March 13th. UBS Group reiterated an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Morgan Stanley upped their price objective on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Finally, Truist Financial set a $100.00 price objective on shares of CVS Health in a report on Wednesday, December 10th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $94.95.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.